FindTrial
Sign In

A study on assessment of mast cells in oral epithelial dysplasia with Toluidine Blue and Hematoxylin and Eosin stains â?? A pilot study

A Study on Assessment of Mast Cells in Oral Epithelial Dysplasia with Toluidine Blue and Hematoxylin and Eosin Stains â?? A Pilot Study - OED

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018691
Enrollment
40
Registered
2019-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Neha Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histopathological sections will be obtained from the archival tissue as well as the cases reported during the study in our institution which are histopathological diagnosed as oral epithelial dysplasia. Subjects without systemic disorders were included for prospective study.

Exclusion criteria

Exclusion criteria: Histopathological sections other than oral epithelial dysplasia will be excluded in the study.

Design outcomes

Primary

MeasureTime frame
To assess the role of mast in oral epithelial dysplasiaTimepoint: 30 days—

Secondary

MeasureTime frame
To see the number of mast cells will vary in different grades of oral epithelial dysplasia & their correlation between themTimepoint: 7 days—

Countries

India

Contacts

Public ContactNeha Singh

Sharda University

ritika.sharma@sharda.ac.in9212140082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026